Mark J. Murray
Direktor/Vorstandsmitglied bei Genevant Sciences Corp.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| William Collier | M | 64 |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | 5 Jahre |
| Michael McElhaugh | M | 50 | 10 Jahre | |
| Frank Torti | M | 45 |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | 6 Jahre |
| Bo Rode Hansen | M | - |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | - |
| Richard Henriques | M | 68 | 10 Jahre | |
| James Meyers | M | 59 | 6 Jahre | |
| David Hastings | M | 62 | 6 Jahre | |
| Daniel Burgess | M | 62 | 7 Jahre | |
| Keith Manchester | M | 55 | 9 Jahre | |
| Mark A. Kay | M | 66 |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | 6 Jahre |
| Karen Sims | M | 53 | 7 Jahre | |
| Peter A. Zorn | M | 53 |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | 5 Jahre |
| Michael Sofia | M | 66 | 9 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Jeffrey Abrams | M | 68 |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | 15 Jahre |
| Timothy M. Ruane | M | 59 | 3 Jahre | |
| Donald Jewell | M | - |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | 14 Jahre |
| Vivek Ramaswamy | M | 38 | 3 Jahre | |
| Koert VandenEnden | M | 45 | 3 Jahre | |
| Ian MacLachlan | M | - |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | 14 Jahre |
| Elizabeth Howard | M | 70 | 7 Jahre | |
| Ronald Ian Lennox | M | 71 |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | 6 Jahre |
| William T. Symonds | M | 56 | 4 Jahre | |
| Bruce Cousins | M | 63 | 5 Jahre | |
| Peter Lutwyche | M | 58 | 10 Jahre | |
| Ken Galbraith | M | 61 | 4 Jahre | |
| Myrtle Potter | F | 65 | 2 Jahre | |
| Arthur M. Bruskin | M | - | 4 Jahre | |
| Dan Kisner | M | 77 | - | |
| Peggy Phillips | F | 70 | 1 Jahre | |
| Frank Karbe | M | 55 | 8 Jahre | |
| Jodi Regts | F | - | 3 Jahre | |
| James Heyes | M | - | 3 Jahre | |
| Gaston Picchio | M | - | 4 Jahre | |
| Tiffany Tolmie | F | - | - | |
| Helia Baradarani | F | - | - | |
| Tom Frohlich | M | 48 | 2 Jahre | |
| Diane Gardiner | F | - | 2 Jahre | |
| K. Michael Forrest | M | 80 | 3 Jahre | |
| R. MacKay-Dunn | M | 73 | - | |
| Patrick T. Higgins | M | 66 | - | |
| Mark Kowalski | M | 69 | 3 Jahre | |
| Ian Mortimer | M | 48 | 16 Jahre | |
| Paul Brennan | M | - | 5 Jahre | |
| Robert S. Whitehead | M | 74 |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | - |
| James W. Hudson | M | - | 3 Jahre | |
| Adam Daniel Cutler | M | 50 | 2 Jahre | |
| Pat R. Brady | M | - |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | - |
| Pieter Cullis | M | - |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | - |
| Gary E. Frashier | M | 86 | 3 Jahre | |
| Jean Jen | F | 37 | 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 44 | 88,00% |
| Kanada | 12 | 24,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Mark J. Murray
- Persönliches Netzwerk